Compare Cronos Group Inc (CRON) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Consumer Staples Select Sector SPDR Fund trades at $83.05 (market cap $13.44B). The key difference: Consumer Staples Select Sector SPDR Fund is far larger — about 11.2× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Consumer Staples Select Sector SPDR Fund for 72 Days on average.
| CRON | XLP | |
|---|---|---|
Market Cap | $1.20B | $13.44B |
Volume | 450,387 | 9,437,177 |
Sector | Health | — |
52-Week High | $3.55 | $90.00 |
52-Week Low | $2.30 | $75.61 |
Typical Hold Time | 22 Days | 72 Days |
Enterprise Value | $401.73M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
XLP trades at $81.70, down 0.09% with a bearish technical outlook as moving averages signal selling pressure. The ETF shows strong analyst support with a 100% buy rating from 2 analysts. Recent news highlights XLP's 6.6% YTD gain outperforming discretionary peers, though it faces headwinds from rising interest rates pressuring dividend stocks.
XLP offers defensive exposure to consumer staples with a low 0.08% expense ratio and upcoming dividend. Key risks include persistent inflation and interest rate sensitivity, but the fund's quality holdings provide stability during market volatility. The technical setup suggests near-term consolidation around current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
